Edwards Lifesciences trading volume on March 16 was $357 million, ranking 330th among U.S. stocks that day.

K-LinePoet

2026-03-24 00:09:51

Abstract generation in progress

On March 16, 2026, Edwards Lifesciences (EW) had a trading volume of $357 million, ranking 330th among U.S. stocks that day. The trading volume decreased by 22.92% compared to yesterday, with a daily trading volume of 4.2707 million shares.

Edwards Lifesciences (EW) rose 2.14% on March 16, 2026, closing at $83.56. The stock has fallen 0.83% over the past 5 trading days, down 3.37% for March, and down 1.98% year-to-date. Over the past 52 weeks, it has increased by 20.59%.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to listings of less than 1 month or fewer than 5 trading days).

Edwards Lifesciences (EW)	Trading Volume / USD	Change in Trading Volume from Yesterday	Trading Volume
March 16, 2026	$357 million	-22.92%	4.2707 million
March 13, 2026	$463 million	29.74%	5.6177 million
March 12, 2026	$357 million	-2.52%	4.224 million
March 11, 2026	$366 million	-31.62%	4.3135 million
March 10, 2026	$535 million	35.02%	6.2658 million

Edwards Lifesciences was incorporated on September 10, 1999, in Delaware. The company is a global leader in structural heart disease, critical care, and surgical monitoring. Driven by a passion to help patients, the company collaborates with leading clinicians and researchers worldwide, investing in R&D to transform care for patients with structural heart disease or those requiring hemodynamic monitoring during surgery or critical care.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes